FDA Approves Eli Lilly’s Zepbound for Sleep Apnea, Expanding its Use in the U.S.
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s weight loss drug, Zepbound, for treating moderate-to-severe obstructive sleep apnea (OSA), the most common sleep-related...